CRISPR: a journey of gene-editing based medicine

被引:0
|
作者
Zhabiz Golkar
机构
[1] Voorhees College,Division of Academic Affairs
来源
Genes & Genomics | 2020年 / 42卷
关键词
CRISPR; Gene-editing; Bacteria; Adaptive immunity; Medicine; DNA; Ethic;
D O I
暂无
中图分类号
学科分类号
摘要
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) is one of the hallmark of biological tools, contemplated as a valid and hopeful alternatives to genome editing. Advancements in CRISPR-based technologies have empowered scientists with an editing kit that allows them to employ their knowledge for deleting, replacing and lately “Gene Surgery”, and provides unique control over genes in broad range of species, and presumably in humans. These fast-growing technologies have high strength and flexibility and are becoming an adaptable tool with implementations that are altering organism’s genome and easily used for chromatin manipulation. In addition to the popularity of CRISPR in genome engineering and modern biology, this major tool authorizes breakthrough discoveries and methodological advancements in science. As scientists are developing new types of experiments, some of the applications are raising questions about what CRISPR can enable. The results of evidence-based research strongly suggest that CRISPR is becoming a practical tool for genome-engineering and to create genetically modified eukaryotes, which is needed to establish guidelines on new regulatory concerns for scientific communities.
引用
收藏
页码:1369 / 1380
页数:11
相关论文
共 50 条
  • [31] Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system
    Yanxia Gao
    Kexin Gao
    Hui Yang
    Cell Regeneration, 10
  • [32] CRISPR/Cas9 gene-editing strategies in cardiovascular cells
    Vermersch, Eva
    Jouve, Charlene
    Hulot, Jean-Sebastien
    CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 894 - 907
  • [33] Next-generation gene-editing platforms drive CRISPR deals
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) : 170 - 170
  • [34] The Legal Battle Around CRISPR Gene-Editing Technology and Its Implications
    Park, Hyeongsu Rick
    Babcock, Brenton
    BIOTECHNOLOGY LAW REPORT, 2017, 36 (02) : 39 - 42
  • [35] The kill-switch for CRISPR that could make gene-editing safer
    Elie Dolgin
    Nature, 2020, 577 (7790) : 308 - 310
  • [36] Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?
    Ahmadi, Fatemeh
    Quach, Angela B. V.
    Shih, Steve C. C.
    BIOMICROFLUIDICS, 2020, 14 (06)
  • [37] The Gene-Editing Conversation
    Nisbet, Matthew
    AMERICAN SCIENTIST, 2018, 106 (01) : 15 - 19
  • [38] CRISPR-Based Gene-Editing Screens Revealed Modulators of Dexamethasone Sensitivity in Multiple Myeloma
    Sobh, Amin
    Bonilla, Emilie
    Patel, Alisha
    Li, Jianping
    Dalal, Mansi
    Riva, Alberto
    Bennett, Richard Lynn
    Licht, Jonathan D.
    BLOOD, 2023, 142
  • [39] Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
    Dong, Wendy
    Kantor, Boris
    VIRUSES-BASEL, 2021, 13 (07):
  • [40] Next-generation CRISPR-based gene-editing therapies tested in clinical trials
    Healey, Natalie
    NATURE MEDICINE, 2024, 30 (09) : 2380 - 2381